Lenalidomide (Revlimid® Celgene), in combination with dexamethasone, has been listed on the PBS for patients with newly diagnosed multiple myeloma who are ineligible for stem cell transplant. Commenting on the new listing, haematologist Professor Miles Prince from the Peter MacCallum Centre said the listing was an important step forward in the fight against myeloma. “Revlimid, which ...
Cancer drugs listed on PBS
1 Feb 2017